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Background: Reliable human in vitro blood–brain barrier (BBB) models suitable for high-throughput screening are
urgently needed in early drug discovery and development for assessing the ability of promising bioactive compounds
to overcome the BBB. To establish an improved human in vitro BBB model, we compared four currently available and
well characterized immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, with
respect to barrier tightness and paracellular permeability. Co-culture systems using immortalized human astrocytes
(SVG-A cell line) and immortalized human pericytes (HBPCT cell line) were designed with the aim of positively
influencing barrier tightness.
Methods: Tight junction (TJ) formation was assessed by transendothelial electrical resistance (TEER)
measurements using a conventional epithelial voltohmmeter (EVOM) and an automated CellZscope system
which records TEER and cell layer capacitance (CCL) in real-time.
Paracellular permeability was assessed using two fluorescent marker compounds with low BBB penetration
(sodium fluorescein (Na-F) and lucifer yellow (LY)). Conditions were optimized for each endothelial cell line by
screening a series of 24-well tissue culture inserts from different providers. For hBMEC cells, further
optimization was carried out by varying coating material, coating procedure, cell seeding density, and growth
media composition. Biochemical characterization of cell type-specific transmembrane adherens junction protein
VE-cadherin and of TJ proteins ZO-1 and claudin-5 were carried out for each endothelial cell line. In addition,
immunostaining for ZO-1 in hBMEC cell line was performed.
Results: The four cell lines all expressed the endothelial cell type-specific adherens junction protein VE-cadherin. The TJ
protein ZO-1 was expressed in hCMEC/D3 and in hBMEC cells. ZO-1 expression could be confirmed in hBMEC cells by
immunocytochemical staining. Claudin-5 expression was detected in hCMEC/D3, TY10, and at a very low level in hBMEC
cells. Highest TEER values and lowest paracellular permeability for Na-F and LY were obtained with mono-cultures of
hBMEC cell line when cultivated on 24-well tissue culture inserts from Greiner Bio-oneW (transparent PET membrane,
3.0 μm pore size). In co-culture models with SVG-A and HBPCT cells, no increase of TEER could be observed, suggesting
that none of the investigated endothelial cell lines responded positively to stimuli from immortalized astrocytic or
pericytic cells.
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Conclusions: Under the conditions examined in our experiments, hBMEC proved to be the most suitable human cell
line for an in vitro BBB model concerning barrier tightness in a 24-well mono-culture system intended for higher
throughput. This BBB model is being validated with several compounds (known to cross or not to cross the BBB),
and will potentially be selected for the assessment of BBB permeation of bioactive natural products.
Keywords: Endothelial cell line, In vitro human blood–brain barrier (BBB) model, 24-well tissue culture insert,
Transendothelial electrical resistance (TEER), Paracellular permeability, CellZscopeBackground
Endothelial microvascular capillary cells in the human
brain constitute a unique cellular barrier to sustain brain
homeostasis and to protect the brain from xenobiotics
and neurotoxic metabolites circulating in the blood-
stream. It has been estimated that more than 98% of
small-molecule drugs are not able to cross the blood–
brain barrier (BBB) [1]. Hence, BBB penetration is a
major challenge in the development of drugs acting on
the central nervous system (CNS), where penetration
into the brain is pivotal for achieving therapeutic effects
[2]. On the other hand, low CNS penetration is desirable
for drugs acting in the periphery. In early drug discovery
and development, new chemical entities (NCEs) are now
screened for their ability to cross the BBB.
For this purpose, a wide range of in silico, in vitro, and
in vivo BBB models for early prediction of brain perme-
ability of compounds have been developed and estab-
lished [3]. Computational models and physicochemical
methods such as the Parallel Artificial Membrane
Permeability Assay (PAMPA-BBB) offer high-throughput
screening capability at early stages of drug discovery, but
are only able to predict passive permeation [4,5]. In con-
trast, in vivo models such as in situ brain perfusion pro-
vide high-quality data and some of the most reliable
measurements of BBB drug penetration [6]. However, they
are expensive in terms of time and resources and, there-
fore, only suitable for testing of compounds at more ad-
vanced stages of development [7]. Cell-based in vitro BBB
models using primary or immortalized brain capillary
endothelial cells from animal or human origin cultivated
on microporous filter membranes of Transwell systems
may bridge the gap between in silico and in vivo studies.
They have been used for in vitro drug BBB permeability
assessment for a long time, and their simple design al-
lows for cost-efficient high-throughput screening [8-10].
Since mono-culture systems represent a highly simpli-
fied model and are far from mimicking in vivo conditions,
further brain-derived cells being part of the neurovascular
unit, such as astrocytes, pericytes, and/or neurons, have
been incorporated into double and triple co-culture
in vitro BBB models [10]. Whereas astrocytes have repeat-
edly been shown to favorably influence barrier tightness of
endothelial cells [11-14], the impact of pericytes on BBBmodels is still a matter of controversy. It was shown
that a syngeneic tri-culture model with primary rat brain
capillary endothelial cells, astrocytes, and pericytes yielded
highest transendothelial electrical resistance (TEER) values
[15]. In contrast, another study showed that a barrier
strengthening effect of pericytes critically depended on
the differentiation state of cells [16].
In vitro animal BBB models using primary or low pas-
sage porcine, bovine, rat, or mouse cells, partly in double
and triple co-culture systems, are generally characterized
by relatively high TEER values and by low paracellular
permeability of marker compounds [17]. Despite these
favorable features, in vitro animal models show major
drawbacks. Isolation and purification procedures of pri-
mary cells are tedious and time-consuming and require
substantial experience [9]. Yields and lifespan of isolated
cells are limited, and animal endothelial cells show dif-
ferences in the expression of drug transporters and ef-
flux pumps when compared to human brain capillary
endothelial cells [18]. The use of primary cultures from
human origin would avoid interspecies pharmacogenetic
variation, yet the availability of these cells is greatly lim-
ited on ethical grounds [19]. Immortalized human brain
capillary endothelial cells can be used as an alternative.
These cells proliferate indefinitely and preserve their dif-
ferentiating properties after repetitive passages, which is
desirable for standardized screenings [9]. However, the
establishment of a reliable human cell-line based BBB
model has proven to be difficult [17]. These cells typically
form only limited restrictive monolayers in vitro, with
TEER values in the range 20 to 200 Ωcm2 [17,20,21].
Compared to in vivo conditions where TEER values have
been estimated to exceed 1000 Ωcm2 [22,23], this is con-
siderably lower. Despite this limitation, in vitro models
with human immortalized cell lines possess several advan-
tages and may be favorable tools for obtaining first mech-
anistic insights into BBB permeability of drugs. However,
optimization of in vitro human BBB models for best bar-
rier tightness is a prerequisite.
This study provides comparative data on four known
immortalized human brain capillary endothelial cell lines,
hCMEC/D3 [24], hBMEC [25], TY10 [26], and BB19 [27],
regarding their ability to form a restrictive barrier in an
in vitro 24-well format BBB model intended for higher
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immortalized human astrocytes (SVG-A cell line [28]) and
immortalized human pericytes (HBPCT cell line [29])
were included into co-culture models with these endothe-
lial cell lines, with the objective to increase barrier tight-
ness. We also present here a large set of in vitro TEER
data recorded for each endothelial cell line cultivated on a
range of tissue culture inserts from different manufac-
turers, with the aid of a CellZscope on-line TEER record-
ing system [30]. This information was important prior to
optimizing an in vitro BBB model with a particular cell
line, since material and pore size of the filter membrane of
the tissue culture inserts have been reported to strongly
affect the adherence of cells and barrier tightness [31,32].
Subsequent optimization of a model with hBMEC cells
was done by systematically screening various coating
materials and coating procedures, by testing a variety
of growth media containing barrier-strengthening com-
pounds, by replacing the commonly used fetal bovine
serum (FBS) with human serum (HS), and by using
astrocyte-conditioned medium (ACM). In addition to
TEER measurements, paracellular permeability of two
fluorescent tracer molecules that do not cross the BBB
in a significant amount (sodium fluorescein (Na-F) and luci-
fer yellow (LY)) was assessed. Biochemical characterization
of VE-cadherin, ZO-1, and claudin-5, three major
components of adherens and tight endothelial junc-
tions, was carried out for each endothelial cell line.




NaCl, CaCl2, MgCl2, KCl, glucose, 4-(2-hydroxyethyl)
piperazine-1-ethanesulfonic acid (HEPES), NaHCO3,
Dulbecco’s modified Eagle medium (DMEM), human
collagen type IV, fibronectin, hydrocortisone (HC), dexa-
methasone, human epidermal growth factor (hEGF),
8-(4-chlorophenylthio) adenosine-3’,5’-cyclic monopho-
sphate sodium salt (8-(4-CPT)cAMP), 4-(3-butoxy-4-
methoxybenzyl) imidazolidin-2-one (RO-20-1724), so-
dium fluorescein (Na-F), radio-immunoprecipitation assay
(RIPA) lysis buffer, phosphate buffered saline (PBS), Triton
X-100, bovine serum albumin (BSA), and 4’,6-diamidino-
2-phenylindole dihydrochloride (DAPI) were purchased
from Sigma-Aldrich (Steinheim, Germany). Fetal bo-
vine serum (FBS) “Gold” was from PAA Laboratories
(Pasching, Austria). Human AB serum (HS) from a
healthy female donor was obtained from the blood donor
bank (Blutspendezentrum Universität Basel, Switzerland).
Both sera were heat inactivated for 30 min at 56°C before
use. EBM-2 and Single-Quots (human vascular endothelial
growth factor, insulin-like growth factor-1, human fibro-
blast growth factor-B, hEGF, ascorbic acid, heparin, andHC) were from Lonza (Basel, Switzerland). Lucifer Yellow
VS dilithium salt (LY) was purchased from Santa Cruz
(Heidelberg, Germany). Antibiotic-antimycotic solution,
secondary antibody (Alexa Fluor 488 conjugation), and
phalloidin (Alexa Fluor 647) were received from Life
Technologies (Paisley, UK). Rat-tail collagen type I and
matrigel were purchased from BD Biosciences (Bedford,
USA) and from Trevigen (Gaithersburg, MD, USA). The
antibodies specific for zonula occludens (ZO)-1 protein,
claudin-5, and vascular endothelial (VE)-cadherin were
from Abcam (Cambridge, UK). Protease inhibitor cocktail
was from Roche (Basel, Switzerland). Tissue culture flasks
were from BD Biosciences (Bedford, USA) and from TPP
(Trasadingen, Switzerland). 24-well tissue culture inserts
and 24-well plates were from Corning IncorporatedW
(Corning, NY, USA), Greiner Bio-oneW (Frickenhausen,
Germany), BD FalconW (Le Pont de Claix, France), MilliporeW
(Billerica, MA, USA), NuncW (Roskilde, Denmark), and
BrandW (Wertheim, Germany).
Cell cultures
In this study, four immortalized human brain capillary
endothelial cell lines, hCMEC/D3 [24], hBMEC [25],
TY10 [26], and BB19 [27], were used (Figure 1). Immor-
talized hCMEC/D3 cell line was kindly provided by Prof.
Pierre-Olivier Couraud (Institut Cochin, Université René
Descartes, Paris, France). hBMEC cell line was obtained
from Prof. Kwang Sik Kim and Prof. Dennis Grab (John
Hopkins University, Baltimore, MD, USA) through the
Swiss Tropical and Public Health Institute (Prof. Reto
Brun, STPH, Basel, Switzerland). TY10 cell line, a new
generation of conditionally immortalized cells coming
from TY08 [33], which was established by the same
method as TY09 cell line [34], was obtained from Prof.
Takashi Kanda (Yamaguchi University Graduate School
of Medicine, Ube, Yamaguchi, Japan). BB19 cells were
kindly provided by Prof. Ashlee V. Moses (Oregon Health
and Science University, Portland, OR, USA). The immor-
talized SVG-A cell line, an astrocytic cell subclone of the
astroglial SVG cell line [28,35], was a generous gift from
Prof. Avindra Nath (National Institute of Neurological
Disorders and Stroke, Bethesda, MD, USA) and the
immortalized human pericyte cell line HBPCT [29] was
provided by Prof. Takashi Kanda (Yamaguchi University
Graduate School of Medicine, Ube, Yamaguchi, Japan).
All cell lines (except TY10) were cultured and grown
to confluence in rat-tail collagen type I coated tissue cul-
ture flasks at 37°C and 5% CO2 in humid atmosphere.
TY10 cells were cultured under similar conditions but at
33°C, since this cell line was immortalized with a hTERT
and a temperature-sensitive SV40 large-T antigen allow-
ing the cells to grow at the permissive temperature of
33°C and to differentiate into physiological endothelial
cells at the non-permissive temperature of 37°C [26,33,34].
Figure 1 Phase contrast microscopy of four immortalized human brain capillary endothelial cell lines. Four endothelial cell lines were
cultured in growth medium containing 20% FBS for 2 days and the representative cell morphology was imaged with a phase contrast
microscope. Scale bar: 150 μm.
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supplemented with Single-Quots, antibiotic-antimycotic so-
lution, and 20% FBS (growth medium 20% FBS). hCMEC/
D3 cells were cultured either in growth medium con-
taining 20% FBS, or in the initial culture medium con-
taining 5% FBS as described previously [24]. Culture
medium for SVG-A and HBPCT cells was DMEM supple-
mented with antibiotic-antimycotic solution and 10% FBS.
For experiments, hCMEC/D3 cells were between passage
(P) 25 and 32, hBMEC cells were between P12 and P25,
TY10 cells between P10 and P19, BB19 cells between P11
and P19, SVG-A cells between P7 and P10, and HBPCT
cells between P13 and P19. All endothelial cell lines used
in this study have been reported to preserve their pheno-
type for a limited range of passages (for hCMEC/D3: up
to P33 [24], for hBMEC: up to P25, for TY10: at least up
to P50 [34], and for BB19: up to P21 [27]).
Biochemical and immunocytochemical characterization of
cellular junctions
Examined cells were lysed in standard RIPA lysis buffer
supplied with protease inhibitor cocktail for 30 min on
ice. Cleared supernatant corresponding to 50 μg of total
protein per sample was subjected to SDS-PAGE and
western blotting analysis. For immunochemistry studies,
hBMEC cells grown on coverslips coated with rat-tail
collagen type I were fixed with paraformaldehyde for
20 min at room temperature and subsequently perme-
abilized with PBS containing 0.2% Triton X-100 for
10 min. The cells were then blocked with 3% BSA for30 min and incubated with ZO-1 antibody (1:100) at 4°C
overnight. Secondary antibody (Alexa Fluor 488 con-
jugation) was incubated together with phalloidin (Alexa
Fluor 647) for 1 h and the representative images were
taken using a fluorescent microscope (Zeiss Z1). The nu-
clei were stained with DAPI.
In vitro co-culture BBB models and TEER measurements
Contact and non-contact co-culture BBB models using
immortalized brain capillary endothelial cells and im-
mortalized astrocytes or immortalized pericytes were
established as follows. hCMEC/D3 (grown with initial
medium), hBMEC, TY10, and BB19 cells were seeded
separately on the apical side of the filter membranes of
24-well tissue culture inserts from CorningW (polycar-
bonate (PC) and polyester (PES) membranes, 0.4 μm
and 3.0 μm pore size), coated with rat-tail collagen type
I (10 μg/cm2). The cell seeding density varied between
3.0 × 104 and 15 × 104 cells/cm2 (hCMEC/D3: 6.0 × 104
cells/cm2, hBMEC: between 3.0 × 104 and 4.5 × 104
cells/cm2, TY10: 3.0 × 104 cells/cm2, and BB19: between
7.5 × 104 and 15 × 104 cells/cm2). Beforehand, SVG-A
or HBPCT cells were seeded on the collagen type I
coated (10 μg/cm2) basal side of the porous filter mem-
brane (SVG-A: between 3.0 × 104 and 9.0 × 104 cells/
cm2, HBPCT: 3.0 × 104 cells/cm2) and allowed to attach
for 1 h. For non-contact models, SVG-A cells were
seeded at a cell density of 1.6 × 104 cells/cm2 onto the
culture plate and incubation thereafter was 2 h (37°C,
5% CO2). After the start of the experiment, TEER values
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thelial voltohmmeter (EVOM) coupled to an Endohm-6
measurement chamber (World Precision Instruments,
USA). Each TEER reading was followed by an exchange
of medium. TEER values for cell layers, expressed in
Ωcm2, were calculated by subtracting the resistance of a
coated control insert without cells from a coated insert
with cells and by subsequent correction for surface area.
For each experiment, at least 2 replicates were mea-
sured. Results are expressed as means ± S.E.M.
Screening of 24-well inserts from different providers for
mono-culture BBB models
For the screening of 24-well tissue culture inserts from
different providers (CorningW, Greiner Bio-OneW, BD
FalconW, MilliporeW, NuncW, and BrandW), each endo-
thelial cell line (hCMEC/D3 (cultured with growth
medium 20% FBS), hBMEC, TY10, and BB19) was
seeded separately on the apical side of the filter mem-
brane at a density varying between 1.5 × 104 and 17 ×
104 cells/cm2. Prior to seeding, the membranes were
coated with rat-tail collagen type I. The tissue culture in-
serts were placed into a 24-well cell module of a CellZ-
scope system (NanoAnalytics, Münster, Germany) [30]
which was placed inside an incubator (37°C and 5%
CO2). For in vitro models with TY10 cells, further exper-
iments were performed for which the CellZscope system
was first placed at 33°C (5% CO2) for 2 days and subse-
quently transferred to 37°C (5% CO2). The medium was
refreshed every 2–4 days. TEER values were recorded in
real-time every hour. TEER values for cell layers, expressed
in Ωcm2, were obtained by subtracting the TEER of a
coated control insert without cells from a coated insert
with cells. After placing the CellZscope system into the in-
cubator, the cell module needs at least 6 h to reach 37°C.
Since TEER values are highly temperature sensitive [36],
recorded TEER values in this time period were not consid-
ered to be valid and are not reported. For each in vitro
experiment, 2 or 3 replicates were measured. Results are
expressed as means ± S.E.M. In addition to TEER values,
the CellZscope system monitors the cell layer capacitance
(CCL) which reflects the membrane surface area. CCL
values in the range of 0.5-5.0 μF/cm2 indicate cell con-
fluency and validate TEER values [37,38]. All reported
TEER values in the result section belong to a CCL within
this range, if not reported otherwise.
Optimization of mono-culture in vitro BBB models
For further optimization of mono-culture systems with
hBMEC, various insert coating procedures using matrigel
(80 μg/cm2) and a mixture of collagen type IV/fibronectin
(80/20 μg/cm2) were assessed. Several growth media were
tested containing compounds such as HC (500 nM; 1500
nM; in addition to HC already included in Single-Quots),dexamethasone (500 nM; 1000 nM), hEGF (50 ng/mL;
100 ng/mL; in addition to hEGF already included in
Single-Quots), 8-(4-CPT)cAMP (250 μM), and RO-20-
1724 (17.5 μM), which have been used in BBB studies to
induce barrier tightness [17,21,39,40]. To avoid cytotoxic
effects of DMSO or ethanol, their final concentration in
the growth medium was below 0.25% [41]. Moreover, a
culture medium (EBM-2, Single-Quots, and antibiotic-
antimycotic solution) called “HS medium” supplemented
with HS (10% and 20%, respectively) instead of FBS was
evaluated. Astrocyte-conditioned media (ACM) were
collected from SVG-A cells cultured with either growth
medium for endothelial cell lines (ACM-1) or culture
medium for SVG-A (ACM-2) and stored at −20°C
until use.
BBB permeability studies with Na-F and LY
To further assess tight junction (TJ) integrity of endo-
thelial cell layers, paracellular permeabilities of Na-F
(MW 376.27) and LY (MW 550.39) were measured. These
two fluorescent, non-P-glycoprotein (P-gp) substrate mol-
ecules have low BBB penetration and are widely used as
barrier integrity markers for in vitro models. To obtain
comparative data, hCMEC/D3 cells, hBMEC cells, and
TY10 cells were seeded onto 24-well tissue culture inserts
(Greiner Bio-oneW, transparent polyethylene terephthalate
(PET) membrane, 3.0 μm pore size, 0.6 × 106 pores/cm2)
and incubated at 37°C (5% CO2) (except TY10 cells) inside
the CellZscope cell module (Figure 2). For TY10, the
CellZscope system was first put at 33°C (5% CO2) for
2 days and was thereafter transferred to 37°C (5% CO2)
for 2 days prior to the permeability assay (Figure 3D). Cell
seeding density for hCMEC/D3 and hBMEC was 6.0 × 104
cells/cm2, and for TY10 it was 3.0 × 104 cells/cm2. For
hBMEC, contact co-culture models with SVG-A cells
(9.0 × 104 cells/cm2) or HBPCT cells (6.0 × 104 cells/cm2)
on the basal side of the coated filter membranes were
tested.
TEER and CCL values before and after the assays were
monitored continuously for integrity control. All experi-
ments for Na-F permeability were carried out at the time
indicated with a black arrow in Figures 3A-D. For LY
permeability assessment, TEER values were in the same
range (graphs not shown). BB19 cells were not included
in this permeability study since TEER values were ex-
tremely low.
For the permeability assay, tissue culture inserts were
transferred into a 24-well plate containing 700 μL of
pre-warmed (37°C) Ringer HEPES buffer (150 mM NaCl,
2.2 mM CaCl2, 0.2 mM MgCl2, 5.2 mM KCl, 2.8 mM
glucose, 5 mM HEPES, and 6 mM NaHCO3, pH 7.4) in
each well (basolateral compartment). Medium in inserts
(apical compartment) was then replaced with 300 μL of
a pre-warmed (37°C) working solution containing Na-F
Figure 2 Scheme of preparation of the in vitro human BBB model. After subculturing the human cell lines for several days, the brain capillary
endothelial cells were seeded on microporous filter membranes of 24-well tissue culture inserts (Greiner Bio-oneW, transparent PET membrane,
3.0 μm pore size). The inserts were immediately transferred to a 24-well cell module of a CellZscope system which was placed inside an incubator
(37°C and 5% CO2). TEER and CCL values were recorded on-line every hour. After 2–4 days (at the maximal TEER), paracellular permeability of Na-F
and LY was assessed. To monitor barrier integrity after the assay, TEER and CCL values were again recorded real-time using the CellZscope system.
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plate was incubated at 37°C on an orbital shaker (ELMI
DTS-2, Riga, Latvia) with moderate speed (100 rpm) and
aliquots of 250 μL of both apical and basolateral com-
partments were collected after 1 h. All experiments were
performed at least in triplicate. Quantification of fluores-
cence (Na-F: excitation 490 nm, emission 514 nm; LY:
excitation 430 nm, emission 535 nm) was carried out
using a Chameleon microplate reader (Hidex, Turku,
Finland). The apparent permeability coefficient (Papp) for
Na-F and LY was calculated in centimeters/second (cm/s)
according to the equation:
Papp cm=sð Þ ¼ VB= ACA0ð Þ  ΔCB=Δtð Þ;
[42] where VB is the volume in the basolateral compart-
ment, A is the surface area of the filter membrane
(0.336 cm2 for Greiner Bio-oneW inserts), CA0 is the initial
concentration in the apical compartment, and ΔCB/Δt is
the change of concentration over time in the basolateral
compartment.
Recovery (mass balance) of Na-F and LY was calcu-
lated with the following equation:
Recovery %ð Þ ¼ CAfVA þ CBfVBð Þ= CA0VAð Þ
 100%;
[43] where CAf and CBf are the final concentrations of
the compound in the apical and basolateral compart-
ment, respectively, CA0 is the initial concentration in the
apical compartment, and VA and VB are the volumes inthe apical and basolateral compartments, respectively.
All results are expressed as means ± S.E.M.
Results
Biochemical and immunocytochemical characterization of
cellular junctions
The four endothelial cell lines all expressed the endothe-
lial marker protein VE-cadherin, albeit at different levels
(Figure 4). The TJ protein ZO-1 was detected in
hCMEC/D3 and in hBMEC at the same level, but it was
expressed at much lower levels in BB19 and TY10 cell
lines (Figure 4). ZO-1 expression in hBMEC cells was
confirmed by immunocytochemical staining (Figure 5).
Claudin-5 was not detected in BB19 cells, but was
expressed at a high level in TY10 cells, at a low level in
hCMEC/D3 cells, and at an even lower level in hBMEC
cells (Figure 4).
Co-culture in vitro BBB models
In the beginning of this study, we aimed to establish an
all-human in vitro BBB model by co-culturing separately
several human brain capillary endothelial cell lines
(hCMEC/D3, hBMEC, TY10, and BB19) with the human
astrocyte cell line SVG-A and with the human pericyte
cell line HBPCT. To find the most effective model re-
garding TJ resistance, each endothelial cell line was
grown separately on the apical filter membrane with
SVG-A cells or HBPCT cells grown on the basal filter
membrane (contact models), or in the culture plate
(non-contact models). Various 24-well tissue culture
Figure 3 Mean TEER values (blue curve) and CCL values (black curve) recorded real-time by the CellZscope system of four human brain
capillary endothelial cell lines grown on 24-well tissue culture inserts. Black arrows indicate the time when the permeability assay with Na-F
was performed (for resulting Papp values see Figures 7A and B). For hCMEC/D3 and TY10, the permeability assay was performed at TEER values in
the range of 10 Ωcm2 (hCMEC/D3: *cultured with initial medium (A), **cultured with growth medium 20% FBS (B). For hBMEC, the assay was
carried out at TEER values in the range of 30 Ωcm2. TEER values after the assay were in the same range or even higher as before, suggesting that
cell layers were robust during the experiment and barrier integrity was maintained (A-D). For each of the three cell lines, CCL values were in the
acceptable range of 0.5-5.0 μF/cm2, indicating that cells were confluent. BB19 cell line (E) yielded very low TEER values in the range of 5 Ωcm2.
Since CCL values were drastically increasing after 55 h, the experiment was stopped. BB19 cells were not included into permeability studies with
Na-F and LY due to their low TEER. All experiments were performed with Greiner Bio-oneW inserts (transparent PET membrane, 3.0 μm pore size,
0.6 × 106 pores/cm2, n = 2–5).
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Figure 4 Western blot analysis of tight junction proteins ZO-1,
claudin-5, and adherens junction protein VE-cadherin from cell
lysates of four endothelial cell lines. The cells were lysed with
RIPA buffer. 50 μg of total protein was subjected to SDS-PAGE and
western blotting analysis for individual markers. Actin was used as
loading control. The four cell lines all expressed the adherens
junction protein VE-cadherin. The TJ protein ZO-1 was detected in
hCMEC/D3, in hBMEC, and at much lower levels in BB19 and TY10
cell lines. Claudin-5 expression was detected in hCMEC/D3, TY10,
and at a very low level in hBMEC cells.
Figure 5 Immunofluorescence staining of tight junction protein
ZO-1 in hBMEC cell line. hBMEC cells were grown on collagen-
coated glass coverslips for 48 h followed by paraformaldehyde
fixation. Even with a high background noise level especially on
nuclei, ZO-1 was detected at the leading edge of migrating hBMEC
cells (see white arrows). Scale bar: 30 μm.
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pore sizes 0.4 μm and 3.0 μm were tested, since these in-
sert types are mostly used for drug transport studies.
Maximal TEER values measured with the EVOM were
obtained with mono-cultures of hBMEC cells (30.7 ±
0.660 Ωcm2 on day 12) on tissue culture insert with PES
membrane and 0.4 μm pore size (Figure 6, red curve).
hBMEC cells grown in contact or non-contact co-
culture models with SVG-A cells on the same kind of in-
serts resulted in lower maximal TEER values (24.3 ± 1.16
Ωcm2 on day 7 and 22.3 ± 0.165 Ωcm2 on day 9, re-
spectively) (Figure 6, blue and black curves). In contact
co-culture models with HBPCT cells, maximal TEER
values were also lower than for hBMEC mono-cultures
(26.2 ± 0.165 Ωcm2 on day 12 compared to 30.7 ± 0.660
Ωcm2 on day 12) (Figure 6, green curve). TEER values
for hBMEC cells on additional tested 24-well tissue cul-
ture inserts, and TEER values for all other models using
hCMEC/D3, TY10, and BB19 cells (in mono-cultures
and in co-cultures), yielded maximal TEER values below
20 Ωcm2 (data not shown). SVG-A cells and HBPCT
cells did not significantly increase or decrease TEER
values (data not shown).Screening of 24-well tissue culture inserts for each
endothelial cell line using the CellZscope
In the above described co-culture experiments, we ob-
served i) that Transwell co-culture models with immor-
talized astrocytes and immortalized pericytes did not
increase TJ resistance of the immortalized brain micro-
vascular endothelial cells included in this study (for
hBMEC, see Figure 6), and ii) that membrane material
and pore size had a significant impact on barrier tight-
ness. Therefore, we decided to optimize mono-culture
models by systematically screening a range of 24-well
tissue culture inserts from various providers (CorningW,
Greiner Bio-oneW, MilliporeW, BD FalconW, NuncW, and
BrandW) for each endothelial cell line, with the aim to
increase TEER. For this screening, an automated CellZ-
scope device [30] was used, which records the TEER
in real-time every hour inside the incubator at 37°C
and 5% CO2. TEER values could not be recorded with
24-well tissue culture inserts from NuncW (PC, 0.4 μm
and 3.0 μm pore size) or BrandW (translucent PC, 0.4 μm
and 3.0 μm pore size), because their particular design
rendered them incompatible with the CellZscope cell
module.
hCMEC/D3 mono-cultures
For hCMEC/D3 monolayers, low TEER values between
5.09 and 11.9 Ωcm2 were obtained on all tested inserts
(Table 1). It was not possible to identify conclusively the
Table 1 Summary of maximal TEER values recorded real-time by the CellZscope system for hCMEC/D3, hBMEC,
and TY10 mono-cultures
24-well tissue culture insert
coated with collagen type I
hCMEC/D3 hBMEC TY10
Time (d) Mean max. TEER ±
S.E.M. (Ωcm2)
Time (d) Mean max. TEER ±
S.E.M. (Ωcm2)
Time (d) Mean max. TEER ±
S.E.M. (Ωcm2)
Corning® (translucent PC, 0.4 μm,
1.0 × 108 pores/cm2, 0.33 cm2)
4.75 6.72 (± 0.113) 2.46 2.79 (± 0.410) 2.37 4.56 (± 1.06)
Corning® (translucent PC, 3.0 μm,
2.0 × 106 pores/cm2, 0.33 cm2)
5.07 8.56 (± 0.217) 5.19 #9.09 (± 0.103) 7.73** #11.2 (± 0.904)
Corning® (transparent PES, 0.4 μm,
4.0 × 106 pores/cm2, 0.33 cm2)
1.97* 7.04 (± 0.231) 2.79* 17.7 (± 0.152) 1.96 6.96 (± 0.199)
Corning® (transparent PES, 3.0 μm,
2.0 × 106 pores/cm2, 0.33 cm2)
3.38 9.44 (± 0.0877) 2.81 6.24 (± 0.0805) 2.37 7.94 (± 0.110)
Greiner Bio-one® (transparent PET,
0.4 μm, 2.0 × 106 pores/cm2, 0.336 cm2)
2.47 6.48 (± 0.125) 1.85 #7.27 (± 2.36) 1.45* 9.37 (± 0.690)
Greiner Bio-one® (translucent PET,
0.4 μm, 1.0 × 108 pores/cm2, 0.336 cm2)
2.34 5.18 (± 0.222) 5.13 7.42 (± 0.288) 1.66* 12.4 (± 2.11)
Greiner Bio-one® (transparent PET,
3.0 μm, 0.6 × 106 pores/cm2, 0.336 cm2)
2.34 11.9 (± 0.118) 2.75 28.4 (± 2.47) 1.15* 13.0 (± 0.0151)
Greiner Bio-one® (translucent PET,
3.0 μm, 2.0 × 106 pores/cm2, 0.336 cm2)
2.34 9.39 (± 0.166) 2.49 5.85 (± 0.357) 1.32* 7.26 (± 0.0949)
Millipore® (translucent PET, 0.4 μm,
1.0 × 108 pores/cm2, 0.33 cm2)
2.34 5.35 (± 0.312) 2.49 2.92 (± 0.164) 1.37* 5.98 (± 0.200)
Millipore® (translucent PET, 3.0 μm,
2.0 × 106 pores/cm2, 0.33 cm2)
2.34 10.2 (± 0.0304) 2.53 15.0 (± 0.348) 2.37 11.2 (± 0.806)
BD Falcon® (transparent PET, 0.4 μm,
2.0 × 106 pores/cm2, 0.3 cm2)
2.34 5.09 (± 0.133) 3.34 8.40 (± 0.524) 3.11 4.72 (± 0.00525)
BD Falcon® (transparent PET, 3.0 μm,
0.8 × 106 pores/cm2, 0.3 cm2)
2.34 8.75 (± 0.180) 3.21 24.1 (± 0.0595) 1.54* 6.19 (± 0.429)
All tested 24-well tissue culture inserts were coated with collagen type I. The cell seeding density varied between 3.0 × 104 and 15 × 104 cells/cm2 for hCMEC/D3,
between 4.5 × 104 and 17 × 104 cells/cm2 for hBMEC, and between 1.5 × 104 and 15 × 104 cells/cm2 for TY10 (n = 2–3).
#CCL outside the acceptable range of 0.5-5.0 μF/cm
2 almost during the whole experiment, indicating that cells were not confluent; PC: polycarbonate;
PES: polyester; PET: polyethylene terephthalate; *before first change of medium; **after third change of medium.
Figure 6 Mean TEER values for hBMEC cell line in mono-cultures and co-cultures with immortalized astrocytes (SVG-A) and immortalized
pericytes (HBPCT). Experiments using 24-well tissue culture inserts from CorningW (transparent PES membrane, 0.4 μm pore size, 4.0 × 106 pores/cm2,
n = 2). Maximal TEER values (30.7 ± 0.660 Ωcm2 on day 12) were obtained with hBMEC mono-cultures. Co-culture models with SVG-A and HBPCT cells
did not result in increased TEER values. Data were recorded with an EVOM coupled to an Endohm-6 measurement chamber.
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differences between TEER values were not significant.
Highest TEER values were observed with 24-well tissue
culture inserts from CorningW (transparent PES mem-
brane, 3.0 μm pore size, 2.0 × 106 pores/cm2), from
MilliporeW (translucent PET membrane, 3.0 μm pore
size, 2.0 × 106 pores/cm2), and from Greiner Bio-oneW
(transparent PET membrane, 3.0 μm pore size, 0.6 × 106
pores/cm2), with a maximum TEER up to 12 Ωcm2
(Table 1). For these experiments, hCMEC/D3 cells were
cultured with growth medium containing 20% FBS to
allow for direct comparisons between all cell lines. When
hCMEC/D3 cells were cultured with initial medium con-
taining 5% FBS, maximal TEER values were in the same
range (around 10 Ωcm2) as when cultured in growth
medium containing 20% FBS (Figures 3A and B).
hBMEC mono-cultures
TEER values of hBMEC monolayers were between 2.79
and 28.4 Ωcm2. The highest value was measured on
24-well tissue culture inserts (transparent PET membrane,
3.0 μm pore size, 0.6 × 106 pores/cm2) from Greiner
Bio-oneW (Table 1 and Figure 3C).
TY10 mono-cultures
TEER values for TY10 monolayers were between 4.56
and 13.0 Ωcm2. The highest value was recorded when
cells were cultured at 37°C from the start of the experi-
ment on inserts from Greiner Bio-oneW (transparent
PET membrane, 3.0 μm pore size, 0.6 × 106 pores/cm2)
(Table 1). TEER values were not increased when cul-
turing TY10 monolayers at the permissive temperature
of 33°C for 2 days before transferring them to 37°C
(Figure 3D).
BB19 mono-cultures
With monolayers of BB19 cells on various 24-well tissue
culture inserts, only extremely low TEER values in the
range of 5 Ωcm2 were obtained (Figure 3E). Despite re-
peated experiments, CCL values remained outside of the
acceptable range of 0.5-5.0 μF/cm2, indicating that cell
layers were not confluent. Since barrier restriction with
such a low TJ resistance was not sufficient for reliable
in vitro BBB models, BB19 cell line was not further in-
cluded in our studies for paracellular tightness assess-
ment using the integrity markers Na-F and LY.
Further optimization of hBMEC mono-cultures
Since TEER values were highest (28.4 ± 2.47 Ωcm2) with
monolayers of hBMEC cells cultivated on Greiner Bio-
oneW inserts (transparent PET membrane, 3.0 μm pore
size, 0.6 × 106 pores/cm2) coated with collagen type I
(Table 1), we optimized this particular mono-culture sys-
tem by varying parameters such as cell seeding density,coating material and procedure, and by testing different
growth media compositions.
Optimization resulted in TEER values in the range of
40 Ωcm2 (Table 2). A maximal TEER value of 43.6 ±
3.89 Ωcm2 (after 3.19 days in vitro) was obtained when
hBMEC cells were cultured under normal growth condi-
tions (growth medium containing 20% FBS) at a seeding
density of 4.5 × 104 cells/cm2 (Table 2). Lower or higher
cell seeding densities resulted in decreased maximal
TEER values (25.9 ± 0.635 Ωcm2 at 3.0 × 104 cells/cm2
and 28.4 ± 2.47 Ωcm2 at 15 × 104 cells/cm2). The duration
of coating the tissue culture inserts with collagen type I
did not have an impact on TEER (data not shown). Coat-
ing the inserts with collagen type IV/fibronectin did not
further improve barrier tightness. However, coating the
tissue culture inserts with matrigel resulted in a decrease
of maximal TEER values (16.6 ± 0.183 Ωcm2 compared to
28.4 ± 2.47 Ωcm2). Growth media containing barrier indu-
cing compounds such as dexamethasone (500 nM and
1000 nM, respectively), 8-(4-CPT)-cAMP (250 μM),
RO-20-1724 (17.5 μM), additional HC (500 nM and
1500 nM, respectively), or additional hEGF (50 ng/mL
and 100 ng/mL, respectively) did not significantly in-
crease the TEER of hBMEC monolayers. Growth medium
supplemented with HS (10% and 20%, respectively) in-
stead of 20% FBS resulted in a decreased maximal TEER
(20.4 ± 0.867 Ωcm2 and 26.2 ± 0.324 Ωcm2, respectively,
compared to 28.4 ± 2.47 Ωcm2). The use of ACM-1 re-
sulted in a decrease of the maximal TEER (13.5 ± 0.614
Ωcm2, compared to 28.4 ± 2.47 Ωcm2). A similar result,
i.e. a decrease of maximal TEER, was obtained when
using a mixture of ACM-2 and growth medium 20%
FBS (1:1) (23.8 ± 0.572 Ωcm2, compared to 28.4 ± 2.47
Ωcm2).
Evaluation of paracellular permeability through
mono-cultures
Since highest TEER values were observed when hBMEC
monolayers were cultured on rat-tail collagen type I
coated Greiner Bio-oneW inserts (transparent PET mem-
brane, pore size 3.0 μm, 0.6 × 106 pores/cm2) at a cell
seeding density of 4.5 × 104 cells/cm2 (Table 1), this in-
sert was selected for permeability studies using Na-F
(MW 376.27) and LY (MW 550.39). For hBMEC cell
line, the mean Papp for Na-F was 5.08 ± 0.220 × 10
-6 cm/s
(Figure 7A). For LY, the mean Papp was 5.39 ± 0.364 ×
10-6 cm/s (Figure 7B). For hCMEC/D3, mean Papp
values for Na-F and LY were 12.5 ± 0.326 × 10-6 cm/s
and 10.0 ± 0.498 × 10-6 cm/s, respectively, when cells
were grown with initial medium containing 5% FBS
(Figures 7A and B). When hCMEC/D3 cells were cul-
tivated with growth medium containing 20% FBS, mean
Papp values for Na-F and LY were 13.4 ± 0.484 × 10
-6 cm/s
and 11.7 ± 0.957 × 10-6 cm/s, respectively (Figures 7A
Table 2 Summary of maximal TEER values recorded real-time by the CellZscope system for hBMEC mono-cultures using
a range of different culture conditions
Culture conditions Cell seeding
density (cells/cm2)
Time (d) Mean max. TEER ±
S.E.M. (Ωcm2)
Cell seeding density: 3.0 × 104 cells/cm2, coating: collagen type I (10 μg/cm2) 3.0 × 104 1.72* 25.9 (± 0.635)
Cell seeding density: 4.5 × 104 cells/cm2, coating: collagen type I (10 μg/cm2) 4.5 × 104 3.19 43.6 (± 3.89)
Growth medium with additional HC (500 nM) for 3 days (only apical),
coating: collagen type I (10 μg/cm2)
4.5 × 104 3.19 43.2 (± 4.27)
Growth medium with additional HC (1500 nM) for 3 days (only apical),
coating: collagen type I (10 μg/cm2)
4.5 × 104 3.19 40.4 (± 0.646)
Cell seeding density: 6.0 × 104 cells/cm2, coating: collagen type I (10 μg/cm2) 6.0 × 104 1.72* 36.3 (± 2.06)
Cell seeding density: 9.0 × 104 cells/cm2, coating: collagen type I (10 μg/cm2) 9.0 × 104 4.15 38.9 (± 0.928)
Growth medium with dexamethasone (500 nM) for 3 days (only apical),
coating: collagen type I (10 μg/cm2)
9.0 × 104 4.15 35.9 (± 0.338)
Growth medium with dexamethasone (1000 nM) for 3 days (only apical),
coating: collagen type I (10 μg/cm2)
9.0 × 104 4.15 38.0 (± 1.26)
Growth medium with additional hEGF (50 ng/mL) for 3 days (only apical),
coating: collagen type I (10 μg/cm2)
9.0 × 104 4.15 36.4 (± 0.902)
Growth medium with additional hEGF (100 ng/mL) for 3 days (only apical),
coating: collagen type I (10 μg/cm2)
9.0 × 104 4.15 40.0 (± 1.94)
Growth medium with 8-(4-CPT)cAMP (250 μM) and RO-20-1724 (17.5 μM)
(apical and basolateral), coating: collagen type I (10 μg/cm2)
9.0 × 104 2.84 20.0 (± 0.509)
Growth medium with 8-(4-CPT)cAMP (250 μM) and RO-20-1724 (17.5 μM),
added after 2 days in vitro (apical and basolateral), coating: collagen type I (10 μg/cm2)
9.0 × 104 2.84 20.9 (± 1.36)
Cell seeding density: 15 × 104 cells/cm2, coating: collagen type I (10 μg/cm2) 15 × 104 2.75 28.4 (± 2.47)
Coating: collagen type IV/fibronectin (80/20 μg/cm2) 15 × 104 2.75 29.3 (± 1.10)
Coating: matrigel (80 μg/cm2) 15 × 104 2.75 16.6 (± 0.183)
Growth medium with 10% HS (apical and basolateral), coating: collagen type I (10 μg/cm2) 15 × 104 1.26* 20.4 (± 0.867)
Growth medium with 20% HS (apical and basolateral), coating: collagen type I (10 μg/cm2) 15 × 104 1.21* 26.2 (± 0.324)
ACM-1 (apical and basolateral), coating: collagen type I (10 μg/cm2) 15 × 104 1.64* 13.5 (± 0.614)
Mixture of ACM-2 and growth medium 20% FBS (1:1) (apical and
basolateral), coating: collagen type I (10 μg/cm2)
15 × 104 3.35 23.8 (± 0.572)
24-Well tissue culture inserts were from Greiner Bio-one® (transparent PET membrane, pore size 3.0 μm, 0.6 × 106 pores/cm2, n = 2–3). *Before first change
of medium.
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were 12.4 ± 0.155 × 10-6 cm/s and 9.68 ± 0.413 × 10-6 cm/s,
respectively (Figures 7A and B). Mean recoveries for Na-F
in all experiments were between 75% and 87% (Figure 7C).
For LY, mean recoveries were between 66% and 79%
(Figure 7D). According to Hubatsch et al. (2007), a
mass balance of at least 80% would be optimal to give
an acceptable approximation of the Papp value [44]. After
each experiment, TEER values were in the same range as
before the assay (or even higher) (Figures 3A-D), suggest-
ing that cell monolayers were robust during the experi-
ment and barrier integrity was maintained.
Evaluation of paracellular permeability through contact
co-cultures
Since lowest Papp values were obtained with hBMEC mono-
layers (Figures 7A and B), we established co-culture models
with SVG-A and HBPCT cells to further assess paracellular
permeability. Mean Papp values for Na-F through hBMECco-cultured with SVG-A and HBPCT cells were 7.43 ±
0.200 × 10-6 cm/s and 8.26 ± 0.893 × 10-6 cm/s, respectively
(compared to 5.08 ± 0.220 × 10-6 cm/s through hBMEC
mono-cultures). Since a culture medium supplemented
with growth factors may mask the potential BBB in-
ducing effect of astrocytes and pericytes, further ex-
periments were performed using culture medium without
growth factors. Mean Papp values for Na-F through
hBMEC monolayers cultured without growth factors was
5.11 ± 0.0487 × 10-6 cm/s (Figure 8). Through hBMEC
cells co-cultured with SVG-A or HBPCT cells using
medium deprived of growth factors, mean Papp values
were slightly higher (6.88 ± 0.516 × 10-6 cm/s and 7.22 ±
0.455 × 10-6 cm/s, respectively) (Figure 8). In all experi-
ments, mean recoveries were between 98% and 102%.
Discussion
There is a need for predictive assays amenable to medium
to high-throughput screening for the assessment of brain
Figure 7 Mean Papp values (A, B) and mean recoveries (C, D) for Na-F and LY through hCMEC/D3, hBMEC, and TY10 monolayers.
24-Well tissue culture inserts from Greiner Bio-oneW (transparent PET membrane, 3.0 μm pore size, 0.6 × 106 pores/cm2) were used (n = 3–5).
A, B: Lowest paracellular permeability of Na-F and LY was obtained through hBMEC monolayers (5.08 ± 0.220 × 10-6 cm/s and 5.39 ± 0.364 ×
10-6 cm/s, respectively). All experiments for Na-F permeability were carried out at the time indicated with a black arrow in Figures 3A-D.
For LY, permeability measurements were carried out at TEER values in the same range (graphs not shown). C, D: Mean recoveries of Na-F
in all experiments were in the range of 75% and 87%. For LY, mean recoveries varied between 66% and 79%. *cultured with initial
medium; **cultured with growth medium 20% FBS.
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talized human brain capillary endothelial cell lines have
been developed and used for the establishment of hu-
man in vitro BBB models [9]. The most extensively
characterized human cell line is the hCMEC/D3 cell line,
which has been reported to represent a promising in vitro
human BBB model for drug transport studies [45,46].
TY10 cell line, transduced with a temperature-sensitive
SV40 large-T antigen, has furthermore been reported to
be a promising and advantageous cell line with excel-
lent expression of TJ proteins such as claudin-5, occlu-
din, and ZO-1 [26]. Whereas at 33°C, TY10 cells can be
cultivated for more than 50 passages without undergoing
morphological changes, a temperature shift from 33°C to
37°C results in the exclusion of the SV40 large-T antigen
as a cancer gene [33,34].
However, monolayers of immortalized human brain
capillary endothelial cell lines are known to form onlymoderately restrictive barriers, with TEER values in the
range of 20–200 Ωcm2 [17,20,21]. To increase barrier
tightness of four currently available human brain capil-
lary endothelial cell lines, hCMEC/D3, hBMEC, TY10,
and BB19 (Figure 1), we tested co-culture models with
immortalized human astrocytes (SVG-A cell line) and
pericytes (HBPCT cell line). Interestingly, we did not ob-
serve an increase of TJ resistance in immortalized hu-
man brain capillary endothelial cells under co-culture
conditions. All co-culture models produced TEER values
that were comparable or lower than those recorded
with mono-cultures (for hBMEC cell line, see Figures 6
and 8A). This suggested that the investigated endothelial
cell lines were unable to respond positively to stimuli from
immortalized astrocytic or pericytic cells.
These findings are in accord with previous reports in
which no additional benefit in terms of TEER was ob-
served when culturing hCMEC/D3 cells with ACM or
Figure 8 Mean TEER (A) and Papp (B) values for hBMEC cultured without growth factors in mono-cultures and contact co-cultures with
SVG-A and HBPCT cells. A: Mean TEER values recorded real-time by the CellZscope system for hBMEC cells cultured without growth factors
(w/o GF) in mono-cultures and co-cultures with SVG-A (black curve) or HBPCT cells (green curve). 24-Well tissue culture inserts from Greiner
Bio-oneW (transparent PET membrane, 3.0 μm pore size, 0.6 × 106 pores/cm2) were used (n = 3). Compared to co-cultures with SVG-A and HBPCT
cells, hBMEC mono-cultures produced higher TEER values in the range of 40 Ωcm2 (blue curve). CCL values were in the acceptable range of
0.5-5.0 μF/cm2 (data not shown), indicating that hBMEC cells were confluent. The black arrow indicates the time when the permeability assay with
Na-F was performed. B: Mean Papp values for Na-F through hBMEC cultured without growth factors through mono-cultures and co-cultures with
SVG-A or HBPCT cells. Lowest Papp values for Na-F (5.11 ± 0.0487 × 10
-6 cm/s) were obtained through hBMEC mono-cultures. Mean recoveries in
all experiments were between 98% and 102% (n = 3).
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trocytes, respectively [24,47]. In contrast, our results do
not support recent findings which showed that TJ resist-
ance of hCMEC/D3 and TY08 cells was significantly in-
creased in co-cultures with human brain astrocytes/
pericytes and HBPCT cells, respectively [29,48]. This di-
vergent effect might possibly be due to the difference of
culture conditions and the nature of cell types.
We observed that membrane material of inserts and
pore size had a significant impact on barrier tightness,
and we optimized mono-culture systems by systematic-
ally screening a large set of 24-well tissue culture inserts
from different providers for each cell line (Table 1).
Highest TEER values (28.4 ± 2.47 Ωcm2) were observed
with hBMEC mono-cultures on 24-well tissue culture
inserts from Greiner Bio-oneW with transparent PET
membrane and 3.0 μm pore size (Table 1). Our findings
clearly show that the selection of an appropriate tissue
culture insert is critical when establishing a BBB model
using these immortalized human brain capillary endo-
thelial cell lines, corroborating previous findings in
which a substantial impact of material characteristics on
the adherence of cells and barrier tightness was demon-
strated [31,32]. hCMEC/D3 and TY10 cells produced
TEER values in the range of 10 Ωcm2 (Table 1). BB19
cells were not included into the screening of tissue cul-
ture inserts, since these cells yielded extremely low
TEER values (around 5 Ωcm2, Figure 3E). These findings
are in agreement with previous studies suggesting thatthe use of BB19 cells as an in vitro model of the human
BBB is limited due to a high sucrose permeability [49].
Surprisingly, we consistently observed lower TEER
values as compared to literature (hCMEC/D3 and hBMEC:
TEER ranging from 40–200 Ωcm2 [21,24,25], TY10: TEER
in the range of 40 Ωcm2 [26]). A possible explanation
may be that we used a different system (automated
CellZscope) for assessment of TEER [30]. Low TEER
values might also arise from a high concentration of
serum and growth factors in the growth medium, which
has been reported to prevent TJ formation between endo-
thelial cells [50]. However, hCMEC/D3 cells cultured with
growth medium containing 5% FBS instead of 20% FBS,
and hBMEC cells cultured in growth medium without
growth factor supplementation did not result in in-
creased TEER values or reduced paracellular permeability
(for hCMEC/D3, see Figures 3A, 3B, Figures 7A, and 7B,
for hBMEC see Figure 8). Furthermore, the selection of
the well format might affect TEER values. Because we
aimed to establish an in vitro BBB model suitable for
higher throughput, we miniaturized the assay to a 24-well
format that was selected previously for a bovine in vitro
BBB model [41].
Subsequent optimization of the hBMEC mono-culture
system resulted in TEER values in the range of 30–40
Ωcm2 (Table 2). We found that the cell seeding density
is critical, since highest TEER values were obtained
when hBMEC cells were seeded at a density ranging be-
tween 4.5 × 104 and 9.0 × 104 cells/cm2 onto coated
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cell growth and TJ development between adjacent cells
on the surface area of the Greiner Bio-oneW inserts
(0.336 cm2). As hBMEC cells are of human origin, we
moreover investigated the effect of HS on barrier tight-
ness. However, no increase in TEER could be observed
(Table 2). These results do not confirm previous findings
that the permeability of sucrose through hCMEC/D3
monolayers could significantly be reduced by HS supple-
mentation [45]. One may speculate that this could be
due to a different type of HS used in these experiments.
An individual HS batch as used for our experiments is
prone to higher batch-to-batch variation in soluble
factors and proteins than pooled HS from commercial
sources.
In the evaluation of paracellular permeability, mean
Papp values for Na-F and LY were significantly lower
with hBMEC monolayers (5.08 ± 0.220 × 10-6 cm/s
and 5.39 ± 0.364 × 10-6 cm/s, respectively) than with
hCMEC/D3 and TY10 monolayers (Figures 7A and B),
corroborating our measurements of TEER values. Perme-
ability values in the order of 10-6 cm/s were obtained pre-
viously in various in vitro BBB models [7,20,39,51].
In the biochemical and immunocytochemical characterization
of cellular junctions, VE-cadherin was detected in all cell
lines, albeit at varying levels (Figure 4). This confirmed
their endothelial lineage. Interestingly, the TJ protein
claudin-5 was expressed at similar levels as VE-cadherin,
confirming that VE-cadherin controls claudin-5 expres-
sion [52]. The cellular junction marker protein ZO-1
showed the same level of expression in hCMEC/D3 and
hBMEC cells, but was expressed only at very low levels in
BB19 and TY10 cells (Figure 4). Furthermore, white
arrows in Figure 5 point to ZO-1 signal at the leading
edge of migrating hBMEC cells, confirming findings
of previous studies [13].
We used an automated CellZscope system [30] in
order to obtain highly standardized data on-line. This
system has several advantages over other methods of
TEER measurement: TEER values are recorded in real-
time every hour in the incubator, thereby reducing work-
load and avoiding any damage of the cell layer during
growth. Also, a disruption of the cell layer is immedi-
ately visible from the recording. In addition, information
about confluency (CCL values) is obtained simultan-
eously, reducing the risk of false interpretation of TEER
values [53]. Experiments with Caco-2 cells on 24-well in-
serts demonstrated that the CellZscope is likewise an ef-
ficient tool for evaluating barrier tightness in other cell
lines, i.e. those used for the study of intestinal drug ab-
sorption. Again, independent of the membrane surface
area, TEER values of Caco-2 monolayers measured with
the CellZscope (24-well format) correlated to off-line
TEER values measured manually with an EVOM using a6-well format (data not shown). One limitation of the
CellZscope system may be its design which does not
allow the seeding of cells on the bottom of the plate. In-
vestigation of triple co-culture model systems is hence
not possible.
Conclusions
In the screening of four available immortalized human
brain capillary endothelial cell lines, hBMEC proved to
be the most suitable and promising cell line for a human
in vitro BBB model in terms of barrier tightness and
paracellular permeability in a 24-well mono-culture
system. hBMEC cells express P-gp [54], claudin-1 [55],
claudin-3 [56], occludin [55-57], ZO-1 [54-56,58], ß-
catenin [58], ICAM-1 [56], and VCAM-1 [56], some of
which were also shown under our experimental condi-
tions (VE-cadherin, ZO-1, and claudin-5, see Figures 4
and 5). Interestingly, although all three examined markers
were detected in hBMEC, the expression level of VE-
cadherin and claudin-5 was much lower than in hCMEC/
D3 and TY10 cells. As a next step, we are currently
validating the hBMEC model with the aid of a series
of compounds known to cross or not to cross the
BBB. After validation, the in vitro human BBB model
will be used for the screening of natural product de-
rived leads, such as GABAA receptor modulators [59],
regarding their ability to pass across the BBB.
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